vs
EDGEWELL PERSONAL CARE Co（EPC）とSotera Health Co（SHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
EDGEWELL PERSONAL CARE Coの直近四半期売上が大きい（$422.8M vs $303.4M、Sotera Health Coの約1.4倍）。Sotera Health Coの純利益率が高く（11.5% vs -15.5%、差は27.0%）。Sotera Health Coの前年同期比売上増加率が高い（4.6% vs -11.6%）。Sotera Health Coの直近四半期フリーキャッシュフローが多い（$52.4M vs $-137.5M）。過去8四半期でSotera Health Coの売上複合成長率が高い（10.6% vs -16.0%）
エッジウェル・パーソナルケアは本社をアメリカ・コネチカット州シェルトンに置く多国籍消費財企業です。パーソナルケア製品を主な事業とし、2015年にエナジャイザー・ホールディングスから分離されて設立され、現在は世界各国で事業を展開しています。
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
EPC vs SHC — 直接比較
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $422.8M | $303.4M |
| 純利益 | $-65.7M | $34.8M |
| 粗利率 | 38.1% | 54.7% |
| 営業利益率 | -4.5% | 23.2% |
| 純利益率 | -15.5% | 11.5% |
| 売上前年比 | -11.6% | 4.6% |
| 純利益前年比 | -3028.6% | 182.8% |
| EPS（希薄化後） | $-1.41 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $422.8M | $303.4M | ||
| Q3 25 | $600.5M | $311.3M | ||
| Q2 25 | $627.2M | $294.3M | ||
| Q1 25 | $580.7M | $254.5M | ||
| Q4 24 | $415.1M | $290.2M | ||
| Q3 24 | $517.6M | $285.5M | ||
| Q2 24 | $647.8M | $276.6M | ||
| Q1 24 | $599.4M | $248.2M |
| Q4 25 | $-65.7M | $34.8M | ||
| Q3 25 | $-30.6M | $48.4M | ||
| Q2 25 | $29.1M | $8.0M | ||
| Q1 25 | $29.0M | $-13.3M | ||
| Q4 24 | $-2.1M | $12.3M | ||
| Q3 24 | $8.8M | $17.0M | ||
| Q2 24 | $49.0M | $8.8M | ||
| Q1 24 | $36.0M | $6.3M |
| Q4 25 | 38.1% | 54.7% | ||
| Q3 25 | 37.9% | 57.0% | ||
| Q2 25 | 42.8% | 56.6% | ||
| Q1 25 | 44.1% | 53.2% | ||
| Q4 24 | 41.6% | 56.6% | ||
| Q3 24 | 41.1% | 55.4% | ||
| Q2 24 | 44.3% | 55.2% | ||
| Q1 24 | 43.1% | 51.2% |
| Q4 25 | -4.5% | 23.2% | ||
| Q3 25 | -4.2% | 23.4% | ||
| Q2 25 | 8.6% | 6.4% | ||
| Q1 25 | 10.1% | -5.8% | ||
| Q4 24 | 2.2% | 30.0% | ||
| Q3 24 | 3.9% | 28.2% | ||
| Q2 24 | 12.8% | 27.8% | ||
| Q1 24 | 11.7% | 21.4% |
| Q4 25 | -15.5% | 11.5% | ||
| Q3 25 | -5.1% | 15.5% | ||
| Q2 25 | 4.6% | 2.7% | ||
| Q1 25 | 5.0% | -5.2% | ||
| Q4 24 | -0.5% | 4.2% | ||
| Q3 24 | 1.7% | 6.0% | ||
| Q2 24 | 7.6% | 3.2% | ||
| Q1 24 | 6.0% | 2.5% |
| Q4 25 | $-1.41 | $0.12 | ||
| Q3 25 | $-0.65 | $0.17 | ||
| Q2 25 | $0.62 | $0.03 | ||
| Q1 25 | $0.60 | $-0.05 | ||
| Q4 24 | $-0.04 | $0.05 | ||
| Q3 24 | $0.18 | $0.06 | ||
| Q2 24 | $0.98 | $0.03 | ||
| Q1 24 | $0.72 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | — | $344.6M |
| 総負債低いほど良い | $1.5B | $2.1B |
| 株主資本純資産 | $1.5B | $606.0M |
| 総資産 | $3.8B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | 1.03× | 3.53× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $344.6M | ||
| Q3 25 | — | $299.2M | ||
| Q2 25 | — | $332.4M | ||
| Q1 25 | — | $304.4M | ||
| Q4 24 | — | $277.2M | ||
| Q3 24 | $209.1M | $306.7M | ||
| Q2 24 | — | $246.1M | ||
| Q1 24 | — | $261.1M |
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.4B | $2.2B | ||
| Q1 25 | $1.4B | $2.2B | ||
| Q4 24 | $1.4B | $2.2B | ||
| Q3 24 | $1.3B | $2.2B | ||
| Q2 24 | $1.3B | $2.2B | ||
| Q1 24 | $1.4B | $2.2B |
| Q4 25 | $1.5B | $606.0M | ||
| Q3 25 | $1.6B | $550.5M | ||
| Q2 25 | $1.6B | $511.3M | ||
| Q1 25 | $1.5B | $414.1M | ||
| Q4 24 | $1.5B | $404.9M | ||
| Q3 24 | $1.6B | $470.2M | ||
| Q2 24 | $1.6B | $422.8M | ||
| Q1 24 | $1.6B | $429.4M |
| Q4 25 | $3.8B | $3.3B | ||
| Q3 25 | $3.8B | $3.2B | ||
| Q2 25 | $3.8B | $3.2B | ||
| Q1 25 | $3.8B | $3.1B | ||
| Q4 24 | $3.7B | $3.1B | ||
| Q3 24 | $3.7B | $3.1B | ||
| Q2 24 | $3.7B | $3.1B | ||
| Q1 24 | $3.8B | $3.1B |
| Q4 25 | 1.03× | 3.53× | ||
| Q3 25 | 0.89× | 3.89× | ||
| Q2 25 | 0.88× | 4.34× | ||
| Q1 25 | 0.95× | 5.36× | ||
| Q4 24 | 0.97× | 5.49× | ||
| Q3 24 | 0.81× | 4.73× | ||
| Q2 24 | 0.82× | 5.26× | ||
| Q1 24 | 0.88× | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-125.9M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $-137.5M | $52.4M |
| FCFマージンFCF / 売上 | -32.5% | 17.3% |
| 設備投資強度設備投資 / 売上 | 2.7% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | — | 2.96× |
| 直近12ヶ月FCF直近4四半期 | $36.3M | $149.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-125.9M | $103.1M | ||
| Q3 25 | $74.1M | $71.2M | ||
| Q2 25 | $114.8M | $57.4M | ||
| Q1 25 | $45.1M | $55.5M | ||
| Q4 24 | $-115.6M | $55.7M | ||
| Q3 24 | $-388.3M | $97.5M | ||
| Q2 24 | $101.2M | $61.3M | ||
| Q1 24 | $129.0M | $9.7M |
| Q4 25 | $-137.5M | $52.4M | ||
| Q3 25 | $46.5M | $35.0M | ||
| Q2 25 | $99.3M | $26.2M | ||
| Q1 25 | $28.0M | $35.6M | ||
| Q4 24 | $-132.4M | $-10.2M | ||
| Q3 24 | $-414.2M | $61.1M | ||
| Q2 24 | $88.6M | $19.4M | ||
| Q1 24 | $117.5M | $-25.2M |
| Q4 25 | -32.5% | 17.3% | ||
| Q3 25 | 7.7% | 11.2% | ||
| Q2 25 | 15.8% | 8.9% | ||
| Q1 25 | 4.8% | 14.0% | ||
| Q4 24 | -31.9% | -3.5% | ||
| Q3 24 | -80.0% | 21.4% | ||
| Q2 24 | 13.7% | 7.0% | ||
| Q1 24 | 19.6% | -10.2% |
| Q4 25 | 2.7% | 16.7% | ||
| Q3 25 | 4.6% | 11.6% | ||
| Q2 25 | 2.5% | 10.6% | ||
| Q1 25 | 2.9% | 7.8% | ||
| Q4 24 | 4.0% | 22.7% | ||
| Q3 24 | 5.0% | 12.7% | ||
| Q2 24 | 1.9% | 15.2% | ||
| Q1 24 | 1.9% | 14.1% |
| Q4 25 | — | 2.96× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | 3.95× | 7.21× | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | — | 4.52× | ||
| Q3 24 | -44.13× | 5.73× | ||
| Q2 24 | 2.07× | 7.00× | ||
| Q1 24 | 3.58× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
